{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-030677","form_type":"8-K","ticker":"FUL","cik":"0000039368","company_name":"FULLER H B CO","filed_at":"2025-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.776725+00:00","generated_at":"2026-05-17T04:22:31.345533+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"H.B. Fuller appoints former J&J MedTech executive Celine Martin to board","bullets":["Celine Martin, 51, elected as Class III director effective Dec. 1, 2025, serving on Audit and Compensation Committees.","Martin most recently served as Company Group Chairman, Cardiovascular & Specialty Solutions at Johnson & Johnson MedTech (2022–2025).","Appointment supports H.B. Fuller's strategic expansion into high-margin medical adhesives and goal of >20% EBITDA margin.","Board size increases to nine directors, eight independent; Martin receives $100K cash retainer and 1,300 RSUs."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-030677","json":"https://secwatch.observer/filing/0001437749-25-030677.json","markdown":"https://secwatch.observer/filing/0001437749-25-030677.md","text":"https://secwatch.observer/filing/0001437749-25-030677.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/0001437749-25-030677-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/39368/000143774925030677/ful20251007_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:22:31.345533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}